23 publications
Name | Date | Type | Actions |
---|---|---|---|
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/07/2008 | Voting rights | |
Pierre Konareff est nommé Directeur Financier et Juridique du Groupe Vétoquinol (french) Vétoquinol annonce la nomination de Pierre Konareff au poste de Directeur Financier et Juridique du groupe. |
08/07/2008 | Public releases | |
Vétoquinol strengthens its presence in Canada in the compagnion animal market Vétoquinol announces the acquisition of the animal health business assets of VETCOM 1979 INC. The animal health business of VETCOM 1979 INC. includes annual revenue of around CAD1.5 million. The company covers nearly 65% of the market for ophthalmological unguents in Canada. |
01/07/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/06/2008 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital as per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
15/05/2008 | Voting rights | |
Satisfactory revenue growth for 1st quarter 2008: +4.6% on a constant basis Revenue for the first quarter of 2008 reached €54.7 M, an increase of 3.0% over the first quarter of 2007, a high revenue growth period. First quarter 2008 growth was particularly significant for the livestock segment. |
06/05/2008 | Public releases | |
Earnings for 2007 attest to strength of business growth model The Vétoquinol board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements. In 2007, Vétoquinol once again achieved significant improvement in its key performance |
18/03/2008 | Public releases | |
VÉTOQUINOL S.A. and JUROX PTY LTD extend their collaboration on ALFAXAN® in Europe |
17/03/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital |
07/03/2008 | Voting rights | |
KIBOW BIOTECH INC. et Vétoquinol S.A. étendent leur accord de commercialisation et de licence vétérinaire pour des applications mondiales (french) |
25/02/2008 | Public releases |